ALDEYRA THERAPEUTICS

aldeyra-therapeutics-logo

Aldeyra Therapeutics is a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. Aldeyra's lead investigational drug product candidates are first-in-class potential treatments in development for dry eye disease, allergic conjunctivitis, proliferative vitreoretinopathy, and Sjรถgren-Larsson Syndrome. The company is also developing other product candidates for retinal and systemic inflammatory diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

ALDEYRA THERAPEUTICS

Social Links:

Industry:
Biotechnology Developer Platform Health Care Therapeutics

Founded:
2004-01-01

Address:
Burlington, Massachusetts, United States

Country:
United States

Website Url:
http://www.aldeyra.com

Total Employee:
11+

Status:
Active

Contact:
(646) 536-7009

Email Addresses:
[email protected]

Total Funding:
287.39 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Current Employees Featured

stephen-g-machatha_image

Stephen G. Machatha
Stephen G. Machatha Chief Development Officer @ Aldeyra Therapeutics
Chief Development Officer

joshua-reed_image

Joshua Reed
Joshua Reed Chief Financial Officer @ Aldeyra Therapeutics
Chief Financial Officer
2018-07-01

todd-c-brady_image

Todd C. Brady
Todd C. Brady CEO @ Aldeyra Therapeutics
CEO
2014-01-01

Founder


not_available_image

John E. Dowling

not_available_image

Thomas A. Jordan

Stock Details


Company's stock symbol is NASDAQ:ALDX

Acquisitions List

Date Company Article Price
2019-01-29 Helio Vision Helio Vision acquired by Aldeyra Therapeutics 25 M USD

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Aldeyra Therapeutics

Key Employee Changes

Date New article
2022-04-28 Aldeyra Therapeutics Announces Chief Financial Officer Transition

Official Site Inspections

http://www.aldeyra.com Semrush global rank: 2.69 M Semrush visits lastest month: 6.16 K

  • Host name: 42.57.196.35.bc.googleusercontent.com
  • IP address: 35.196.57.42
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Aldeyra Therapeutics" on Search Engine